IBDEI39F ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,54782,1,3,0)
 ;;=3^Bladder Disorders,Other Spec
 ;;^UTILITY(U,$J,358.3,54782,1,4,0)
 ;;=4^N32.89
 ;;^UTILITY(U,$J,358.3,54782,2)
 ;;=^87989
 ;;^UTILITY(U,$J,358.3,54783,0)
 ;;=N33.^^256^2771^4
 ;;^UTILITY(U,$J,358.3,54783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54783,1,3,0)
 ;;=3^Bladder Disorders,Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,54783,1,4,0)
 ;;=4^N33.
 ;;^UTILITY(U,$J,358.3,54783,2)
 ;;=^5015654
 ;;^UTILITY(U,$J,358.3,54784,0)
 ;;=N34.2^^256^2771^99
 ;;^UTILITY(U,$J,358.3,54784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54784,1,3,0)
 ;;=3^Urethritis
 ;;^UTILITY(U,$J,358.3,54784,1,4,0)
 ;;=4^N34.2
 ;;^UTILITY(U,$J,358.3,54784,2)
 ;;=^88231
 ;;^UTILITY(U,$J,358.3,54785,0)
 ;;=N34.1^^256^2771^100
 ;;^UTILITY(U,$J,358.3,54785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54785,1,3,0)
 ;;=3^Urethritis,Nonspec
 ;;^UTILITY(U,$J,358.3,54785,1,4,0)
 ;;=4^N34.1
 ;;^UTILITY(U,$J,358.3,54785,2)
 ;;=^5015655
 ;;^UTILITY(U,$J,358.3,54786,0)
 ;;=N39.0^^256^2771^104
 ;;^UTILITY(U,$J,358.3,54786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54786,1,3,0)
 ;;=3^Urinary Tract Infection,Site Not Spec
 ;;^UTILITY(U,$J,358.3,54786,1,4,0)
 ;;=4^N39.0
 ;;^UTILITY(U,$J,358.3,54786,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,54787,0)
 ;;=N31.0^^256^2771^72
 ;;^UTILITY(U,$J,358.3,54787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54787,1,3,0)
 ;;=3^Neuropathic Bladder,Uninhibited NEC
 ;;^UTILITY(U,$J,358.3,54787,1,4,0)
 ;;=4^N31.0
 ;;^UTILITY(U,$J,358.3,54787,2)
 ;;=^5015644
 ;;^UTILITY(U,$J,358.3,54788,0)
 ;;=R31.9^^256^2771^54
 ;;^UTILITY(U,$J,358.3,54788,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54788,1,3,0)
 ;;=3^Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,54788,1,4,0)
 ;;=4^R31.9
 ;;^UTILITY(U,$J,358.3,54788,2)
 ;;=^5019328
 ;;^UTILITY(U,$J,358.3,54789,0)
 ;;=R31.0^^256^2771^52
 ;;^UTILITY(U,$J,358.3,54789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54789,1,3,0)
 ;;=3^Hematuria,Gross
 ;;^UTILITY(U,$J,358.3,54789,1,4,0)
 ;;=4^R31.0
 ;;^UTILITY(U,$J,358.3,54789,2)
 ;;=^5019325
 ;;^UTILITY(U,$J,358.3,54790,0)
 ;;=R31.2^^256^2771^53
 ;;^UTILITY(U,$J,358.3,54790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54790,1,3,0)
 ;;=3^Hematuria,Microscopic
 ;;^UTILITY(U,$J,358.3,54790,1,4,0)
 ;;=4^R31.2
 ;;^UTILITY(U,$J,358.3,54790,2)
 ;;=^5019327
 ;;^UTILITY(U,$J,358.3,54791,0)
 ;;=R31.1^^256^2771^51
 ;;^UTILITY(U,$J,358.3,54791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54791,1,3,0)
 ;;=3^Hematuria,Benign Essential Microscopic
 ;;^UTILITY(U,$J,358.3,54791,1,4,0)
 ;;=4^R31.1
 ;;^UTILITY(U,$J,358.3,54791,2)
 ;;=^5019326
 ;;^UTILITY(U,$J,358.3,54792,0)
 ;;=N40.0^^256^2771^30
 ;;^UTILITY(U,$J,358.3,54792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54792,1,3,0)
 ;;=3^Enlarged Prostate w/o Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,54792,1,4,0)
 ;;=4^N40.0
 ;;^UTILITY(U,$J,358.3,54792,2)
 ;;=^5015689
 ;;^UTILITY(U,$J,358.3,54793,0)
 ;;=N40.1^^256^2771^29
 ;;^UTILITY(U,$J,358.3,54793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54793,1,3,0)
 ;;=3^Enlarged Prostate w/ Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,54793,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,54793,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,54794,0)
 ;;=N41.0^^256^2771^82
 ;;^UTILITY(U,$J,358.3,54794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54794,1,3,0)
 ;;=3^Prostatitis,Acute
 ;;^UTILITY(U,$J,358.3,54794,1,4,0)
 ;;=4^N41.0
 ;;^UTILITY(U,$J,358.3,54794,2)
 ;;=^259106
 ;;^UTILITY(U,$J,358.3,54795,0)
 ;;=N45.1^^256^2771^31
 ;;^UTILITY(U,$J,358.3,54795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,54795,1,3,0)
 ;;=3^Epididymitis
